|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-9-10
|
|
pubmed:abstractText |
The objective of this study was to determine whether baseline albuminuria predicts coronary artery calcification (CAC) progression in subjects with type 1 diabetes and whether angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II type I receptor blocker (ARB) treatment is associated with lower odds of CAC progression.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1056-8727
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
273-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17825750-Adult,
pubmed-meshheading:17825750-Albuminuria,
pubmed-meshheading:17825750-Angiotensin II Type 2 Receptor Blockers,
pubmed-meshheading:17825750-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:17825750-Antihypertensive Agents,
pubmed-meshheading:17825750-Calcinosis,
pubmed-meshheading:17825750-Coronary Disease,
pubmed-meshheading:17825750-Diabetes Mellitus, Type 1,
pubmed-meshheading:17825750-Diabetic Angiopathies,
pubmed-meshheading:17825750-Disease Progression,
pubmed-meshheading:17825750-Female,
pubmed-meshheading:17825750-Humans,
pubmed-meshheading:17825750-Hypertension,
pubmed-meshheading:17825750-Male,
pubmed-meshheading:17825750-Middle Aged,
pubmed-meshheading:17825750-Regression Analysis
|
|
pubmed:articleTitle |
ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
|
|
pubmed:affiliation |
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA. david.maahs@uchsc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, N.I.H., Extramural
|
